Literature DB >> 15348298

Human monocyte-derived macrophages and dendritic cells as targets for biomaterial cytocompatibility studies using an improved in vitro culture system.

E Mebouta-Nkamgueu1, J J Adnet, D Ittelet, D Laurent-Maquin, S Bouthors, G Potron, M Guenounou, J Bernard.   

Abstract

Since macrophage plays a key role in the biocompatibility process, neoplastic macrophage cell lines and human blood monocytes are commonly used as target cells for in vitro biomaterial tolerance evaluation. However, tumor cells profoundly differ from normal tissue cells and monocytes are only precursors of macrophages. It has become possible to generate recently, under adherent-free conditions, fully mature macrophages and dendritic cells from human blood monocytes in the presence of GM-CSF and GM-CSF + IL4 respectively. In the present work, we examined the effects of titanium-alloy on morphology, adhesion, cell phenotype and TNF-alpha release activity of such differentiated cells grown in hydrophobic teflon bags. Scanning electron microscopy showed that macrophages substantially adhered and spread on titanium-alloy surface throughout the culture period, whereas only a few dendritic cells were adherent. The phenotype of both cell types remained unchanged in the presence of the tested material. However, titanium-alloy stimulated the secretion of TNF-alpha by the macrophages of some donors. This model of culture may offer new insights into the biomaterial evaluation and may be useful for studying individual responses induced by biomaterials. Copyright 2001 Kluwer Academic Publishers

Entities:  

Year:  2001        PMID: 15348298     DOI: 10.1023/a:1011255406438

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  41 in total

1.  Titanium, chromium and cobalt ions modulate the release of bone-associated cytokines by human monocytes/macrophages in vitro.

Authors:  J Y Wang; B H Wicklund; R B Gustilo; D T Tsukayama
Journal:  Biomaterials       Date:  1996-12       Impact factor: 12.479

2.  Interactions of osteoblasts and macrophages with biodegradable and highly porous polyesterurethane foam and its degradation products.

Authors:  B Saad; S Matter; G Ciardelli; G K Uhlschmid; M Welti; P Neuenschwander; U W Suter
Journal:  J Biomed Mater Res       Date:  1996-11

3.  Macrophage/particle interactions: effect of size, composition and surface area.

Authors:  A S Shanbhag; J J Jacobs; J Black; J O Galante; T T Glant
Journal:  J Biomed Mater Res       Date:  1994-01

4.  A study on the effects of particulate metals of orthopaedic interest on murine macrophages in vitro.

Authors:  T Rae
Journal:  J Bone Joint Surg Br       Date:  1975-11

5.  Interleukin-1 production by mononuclear cells from rheumatoid synovial effusions.

Authors:  N Bhardwaj; L L Lau; M Rivelis; R M Steinman
Journal:  Cell Immunol       Date:  1988-07       Impact factor: 4.868

6.  Human monocyte response to particulate biomaterials generated in vivo and in vitro.

Authors:  A S Shanbhag; J J Jacobs; J Black; J O Galante; T T Glant
Journal:  J Orthop Res       Date:  1995-09       Impact factor: 3.494

7.  Bone resorption activity of particulate-stimulated macrophages.

Authors:  T T Glant; J J Jacobs; G Molnár; A S Shanbhag; M Valyon; J O Galante
Journal:  J Bone Miner Res       Date:  1993-09       Impact factor: 6.741

8.  Human macrophage response to retrieved titanium alloy particles in vitro.

Authors:  W J Maloney; R E James; R L Smith
Journal:  Clin Orthop Relat Res       Date:  1996-01       Impact factor: 4.176

9.  The characterization of cytokines in the interface tissue obtained from failed cementless total hip arthroplasty with and without femoral osteolysis.

Authors:  J Chiba; H E Rubash; K J Kim; Y Iwaki
Journal:  Clin Orthop Relat Res       Date:  1994-03       Impact factor: 4.176

10.  Proliferating dendritic cell progenitors in human blood.

Authors:  N Romani; S Gruner; D Brang; E Kämpgen; A Lenz; B Trockenbacher; G Konwalinka; P O Fritsch; R M Steinman; G Schuler
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.